Capital expenditure decreased 50.4%
Capital expenditure changed -50.4% from the comparable as-filed period. The change ranks at the 80th percentile of 5 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -50.4% from the comparable as-filed period. The change ranks at the 80th percentile of 5 prior comparable changes.
Cash & equivalents changed -68.2% from the comparable as-filed period.
Free-cash-flow proxy changed +38.6% from the comparable as-filed period. The change ranks at the 0th percentile of 5 prior comparable changes.
Gross profit changed -21.3% from the comparable as-filed period.
Inventory changed -53.9% from the comparable as-filed period.
Net income changed +82.0% from the comparable as-filed period.
Operating cash flow changed +37.4% from the comparable as-filed period. The change ranks at the 20th percentile of 5 prior comparable changes.
Operating income changed +81.7% from the comparable as-filed period.
Operating margin changed +5150 basis points from the comparable as-filed period.
Stock-based compensation changed -66.5% from the comparable as-filed period.
Capex / revenue changed -96 basis points from the comparable as-filed period.
Revenue changed -19.9% from the comparable as-filed period.
Gross margin changed -51 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.